{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:19:18Z","timestamp":1763036358359},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1986,5,1]],"date-time":"1986-05-01T00:00:00Z","timestamp":515289600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can Anaesth Soc J"],"published-print":{"date-parts":[[1986,5]]},"DOI":"10.1007\/bf03010752","type":"journal-article","created":{"date-parts":[[2008,12,14]],"date-time":"2008-12-14T07:06:29Z","timestamp":1229238389000},"page":"371-378","source":"Crossref","is-referenced-by-count":17,"title":["The anaesthetic management of the malignant hyperthermia susceptible parturient"],"prefix":"10.1007","volume":"33","author":[{"given":"M. Joanne","family":"Douglas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham H.","family":"McMorland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03010752_CR1","first-page":"1244","volume":"1","author":"JS Crawford","year":"1972","unstructured":"Crawford JS. Hyperpyrexia during pregnancy. Lancet 1972; 1:1244.","journal-title":"Lancet"},{"key":"BF03010752_CR2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/bja\/51.9.899","volume":"51","author":"F Liebenschutz","year":"1979","unstructured":"Liebenschutz F, Mai C, Pickerodt VWA. Increased carbon dioxide production in two patients with malignant hyperthermia and its control by dantrolene. Br J Anaesth 1979; 51:899\u2013903.","journal-title":"Br J Anaesth"},{"key":"BF03010752_CR3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2044.1979.tb04865.x","volume":"34","author":"SM Willatts","year":"1979","unstructured":"Willatts SM. Malignant hyperthermia susceptibility \u2014 management during pregnancy and labour. Anaesthesia 1979; 34:41\u20136.","journal-title":"Anaesthesia"},{"key":"BF03010752_CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00000542-197701000-00011","volume":"46","author":"RK Wadhwha","year":"1977","unstructured":"Wadhwha RK. Obstetric anesthesia for a patient with malignant hyperthermia susceptibility. Anesthesiology 1977; 46:63\u20134.","journal-title":"Anesthesiology"},{"key":"BF03010752_CR5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1213\/00000539-198301000-00022","volume":"62","author":"SN Khalil","year":"1983","unstructured":"Khalil SN, Williams JP, Bourke DL. Management of a malignant hyperthermia susceptible patient in labor with 2-chloroprocaine epidural anesthesia. Anesth Analg 1983; 62:119\u201321.","journal-title":"Anesth Analg"},{"key":"BF03010752_CR6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0002-9378(84)90378-8","volume":"150","author":"JP Cupryn","year":"1984","unstructured":"Cupryn JP, Kennedy A, Byrick RJ. Malignant hyperthermia in pregnancy. Am J Obstet Gynecol 1984; 150:327\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"BF03010752_CR7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00000542-198202000-00010","volume":"56","author":"FJ Lips","year":"1982","unstructured":"Lips FJ, Newland M, Dutton G. Malignant hyperthermia triggered by cyclopropane during Cesarean section. Anesthesiology 1982; 56:144\u20136.","journal-title":"Anesthesiology"},{"key":"BF03010752_CR8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/0310057X8401200203","volume":"12","author":"JM Gibbs","year":"1984","unstructured":"Gibbs JM. Unexplained hyperpyrexia during labor (letter). Anaesth Intensive Care 1984; 12:375.","journal-title":"Anaesth Intensive Care"},{"key":"BF03010752_CR9","first-page":"299","volume":"25","author":"MJ Douglas","year":"1983","unstructured":"Douglas MJ, O\u2019Connor GA, Allanson JE. Malig- nant hyperthermia in British Columbia. BC Med J 1983; 25:299\u2013300.","journal-title":"BC Med J"},{"key":"BF03010752_CR10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00000542-198011000-00007","volume":"53","author":"GA Gronert","year":"1980","unstructured":"Gronert GA. Malignant hyperthermia. Anesthesiology 1980; 53:395\u2013423.","journal-title":"Anesthesiology"},{"key":"BF03010752_CR11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF03007440","volume":"27","author":"K Sewall","year":"1980","unstructured":"Sewall K, Flowerdew RMM, Bromberger P. Severe muscular rigidity at birth: malignant hyperthermia syndrome? Can Anaesth Soc J 1980; 27:279\u201382.","journal-title":"Can Anaesth Soc J"},{"key":"BF03010752_CR12","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/bmj.3.5982.511","volume":"3","author":"FR Ellis","year":"1975","unstructured":"Ellis FR, Clarke IMC, Modgill M, CurrieS, Harriman DGF. Evaluation of creatinine phosphokinase in screening patients for malignant hyperpyrexia. Br Med J 1975; 3:511\u20133.","journal-title":"Br Med J"},{"key":"BF03010752_CR13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1471-0528.1975.tb00647.x","volume":"82","author":"DM Isherwood","year":"1975","unstructured":"Isherwood DM, Ridley J, Wilson J. Creatine phosphokinase (CPK) levels in pregnancy: a case report and a discussion of the value of CPK levels in the prediction of possible malignant hyperpyrexia. Br J Obstet Gynaecol 1975; 82:346\u20139.","journal-title":"Br J Obstet Gynaecol"},{"key":"BF03010752_CR14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF03015127","volume":"32","author":"PG Duncan","year":"1985","unstructured":"Duncan PG. Availability of dantrolene in Canadian hospitals. (Editorial) Can Anaesth Soc J 1985; 32:205\u20139.","journal-title":"(Editorial) Can Anaesth Soc J"},{"key":"BF03010752_CR15","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/BF03011418","volume":"32","author":"BA Britt","year":"1985","unstructured":"Britt BA. Malignant hyperthermia. Can Anaesth Soc J 1985; 32:666\u201377.","journal-title":"Can Anaesth Soc J"},{"key":"BF03010752_CR16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00000542-198101000-00014","volume":"54","author":"DC Fitzgibbons","year":"1981","unstructured":"Fitzgibbons DC. Malignant hypothermia following pre-operative oral administration of dantrolene. Anesthesiology 1981; 54:73\u20135.","journal-title":"Anesthesiology"},{"key":"BF03010752_CR17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00000542-198310000-00002","volume":"59","author":"EH Flewellen","year":"1983","unstructured":"Flewellen EH, Nelson TE, Jones WP, Arens JF, Wagner DL. Dantrolene dose response in awake man: implications for management of malignant hyperthermia. Anesthesiology 1983; 59:275\u2013280.","journal-title":"Anesthesiology"},{"key":"BF03010752_CR18","first-page":"265","volume":"59","author":"DH Morison","year":"1983","unstructured":"Morison DH. Placental transfer of dantrolene. Anesthesiology 1983; 59:265.","journal-title":"Anesthesiology"},{"key":"BF03010752_CR19","doi-asserted-by":"crossref","first-page":"A 404","DOI":"10.1097\/00000542-198409001-00404","volume":"51","author":"R Glassenberg","year":"1984","unstructured":"Glassenberg R, Cohen H. Intravenous dantrolene in a pregnant malignant hyperthermia susceptible (MHS) patient. Anesthesiology 1984; 51:A 404.","journal-title":"Anesthesiology"},{"key":"BF03010752_CR20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0002-9378(83)90076-5","volume":"147","author":"SM Shnider","year":"1983","unstructured":"Shnider SM, Abboud TK, Artal R, Henriksen EH, Stefani SJ, Levinson G. Maternal catecholamines decrease during labor after lumbar epidural anesthesia. Am J Obstet Gynecol 1983; 147:13\u20135.","journal-title":"Am J Obstet Gynecol"},{"key":"BF03010752_CR21","unstructured":"The Communicator (Newsletter of the Malignant Hyperthermia Association of the United States) 1985; Vol III, No. 4 Spring."},{"key":"BF03010752_CR22","doi-asserted-by":"crossref","first-page":"A209","DOI":"10.1097\/00000542-198409001-00209","volume":"61","author":"R Rosenblatt","year":"1984","unstructured":"Rosenblatt R, Tollman RD, Weaver J, Wang Y. Dantrolene potentiates the toxicity of bupivacaine. Anesthesiology 1984; 61:A209.","journal-title":"Anesthesiology"},{"key":"BF03010752_CR23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF03013807","volume":"30","author":"R Grinberg","year":"1983","unstructured":"Grinberg R, Edelist G, Gordon A. Postoperative malignant hyperthermia episodes in patients who received \u201csafe\u201d anaesthetics. Can Anaesth Soc J 1983; 30:273\u20136.","journal-title":"Can Anaesth Soc J"}],"container-title":["Canadian Anaesthetists\u2019 Society Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03010752.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03010752\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03010752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T22:41:25Z","timestamp":1558478485000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03010752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,5]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1986,5]]}},"alternative-id":["BF03010752"],"URL":"https:\/\/doi.org\/10.1007\/bf03010752","relation":{},"ISSN":["0008-2856","1496-8975"],"issn-type":[{"value":"0008-2856","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,5]]}}}